GSK, J&J Back New $198.5M Incubator Fund
Pharmaceutical giants GlaxoSmithKline PLC and Johnson & Johnson have put their weight behind a new €150 million ($198.5 million) venture capital fund promoting life science startups, in a rare step that...To view the full article, register now.
Already a subscriber? Click here to view full article